Pelareorep Completed Phase 2 Trials for Pancreatic Ductal Adenocarcinoma (PDAC) / Stage IV Pancreatic Cancer / Recurrent Pancreatic Carcinoma / Acinar cell carcinoma of pancreas Treatment

Indications	Status	Purpose	Phase
DBCOND0082002 (Pancreatic Ductal Adenocarcinoma (PDAC)) DBCOND0028776 (Stage IV Pancreatic Cancer) DBCOND0043478 (Recurrent Pancreatic Carcinoma) DBCOND0010823 (Acinar cell carcinoma of pancreas)	Completed	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT01280058	Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer	Carboplatin (DB00958) Paclitaxel (DB01229) Pelareorep (DB17284)